Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

22 Apr 2014 12:27

Killik hails major Glaxo deal with Novartis

Killik has maintained a 'buy' recommendation on GlaxoSmithKline (GSK), saying that the company's major three-part transaction with Swiss pharmaceuticals peer Novartis on Tuesday will accelerate growth, provide cost savings and generate increased returns. The first part of the deal will see GSK and

Read more
22 Apr 2014 12:09

UK MIDDAY BRIEFING: Drug Stocks Soar, Led By Glaxo And AstraZeneca

LONDON (Alliance News) - Pharmaceutical stocks are reigning over the first session following the long Easter bank holiday, with mergers and acquisitions leading investor interest.

GlaxoSmithKline has signed a three-part inter-conditional transaction with Swiss healt

Read more
22 Apr 2014 11:36

London midday: Pharma deals lift stocks as FTSE 100 nears 6,700

- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,741.04 +2.28% FTSE 100 6,691.88 +1.01% FTSE 250 16,103.19 +1.23% Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tues

Read more
22 Apr 2014 11:35

US STOCKS-Futures flat, but Netflix jumps in premarket

* S&P 500, Nasdaq coming off five-day advances * Netflix jumps, results show strong subscriber growth * Rail stocks could benefit from delay in Keystone pipeline * Futures up: Dow 11 pts, S&P 0.6 pt, Nasdaq 9.75 pts By Ryan Vlastelica NEW YORK, April 22 (Reuters) - U

Read more
22 Apr 2014 10:58

UK WINNERS & LOSERS: Pharmaceutical Companies Jump On M&A News

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 - WINNERS
-------
AstraZeneca, up 7.1%. The pharmaceutical company has jumped after The Sunday

Read more
22 Apr 2014 10:46

TOP NEWS: Glaxo Signs Three-Part Deal With Switzerland's Novartis

LONDON (Alliance News) - The following is a summary of top news stories Tuesday.
----------
COMPANIES
----------
GlaxoSmithKline PLC said it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off i

Read more
22 Apr 2014 09:47

Novartis shake-up, Pfizer-AstraZeneca report lifts pharma stocks

LONDON, April 22 (Reuters) - Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GlaxoSmithKline and reports U.S. giant Pfizer had approached Britain's AstraZeneca over a deal. Pfizer and Astr

Read more
22 Apr 2014 09:33

MARKET COMMENT: Pharmaceutical Stocks Lead FTSE Higher On M&A

LONDON (Alliance News) - Pharmaceutical companies are leading UK stocks higher Tuesday, with the sector buoyed by merger and acquisition activity and speculation. With little in the way of economic data to provide focus, and in the absence of a further deterioration of the political situati

Read more
22 Apr 2014 08:59

London open: Pharma M&A gives UK stocks a lift

- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,729.51 +1.85% FTSE 100 6,683.16 +0.87% FTSE 250 16,031.64 +0.78% Strong gains from heavyweight pharmaceutical groups gave UK markets a boost on Tuesd

Read more
22 Apr 2014 07:46

GlaxoSmithKline says Novartis deal could lead to more disposals

LONDON, April 22 (Reuters) - GlaxoSmithKline said the group's deal with Novartis narrowed its focus on the key areas of vaccines, respiratory, consumer and HIV medicines, and could be followed by the disposal of its portfolio of older drugs. Chief Executive Andrew Witty said the core areas

Read more
22 Apr 2014 07:39

UK MORNING BRIEFING: Glaxo And AstraZeneca Put M&A In Focus

LONDON (Alliance News) - UK shares have opened slightly higher Tuesday following gains on Wall Street over the long Easter weekend.

Merger and acquisition activity and discussion surrounding UK pharmaceutical giants GlaxoSmithKline and AstraZeneca

Read more
22 Apr 2014 07:29

BUZZ-Healthcare M&A: what the doctor ordered

A spate of deal headlines in the European pharma sector is putting a floor under regional stock indices. ** Busy Easter for dealmakers with Novartis and GlaxoSmithKline leading the charge. ** Pfizer could get back into mega-deal mode after a 4-year hiatus. A reported 60 billion pound

Read more
22 Apr 2014 07:04

Glaxo announces massive three-part deal with Swiss peer Novartis - UPDATE

- GSK to return 4bn pounds to shareholders after Novartis three-part deal - Companies to create new consumer business - Novartis to sell Vaccines business to GSK - GSK to sell Oncology portfolio to Novartis - Means 10bn dollar surplus payment to GSK GlaxoSmithKline (GSK) has announced a major three

Read more
22 Apr 2014 06:52

UPDATE: GlaxoSmithKline Inks Deal With Novartis To Sell Oncology Portfolio, Acquire Vaccines Business

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off its Oncology portfolio, acquire Novartis' global Vaccines business, and create a dually-offered Consumer Healthcare business. The tr

Read more
22 Apr 2014 06:41

MARKET COMMENT: UK Stocks To Open Slightly Higher With M&A In Focus

LONDON (Alliance News) - UK stocks are set to open marginally higher Tuesday, as European markets play catch-up with Wall Street, which made gains over the long Easter weekend despite ongoing tensions in Ukraine. Spreadbetters are indicating that the FTSE 100 will open slightly higher Tuesd

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.